Accelerate Diagnostics AXDX reported its Q2 earnings results on Monday, August 15, 2022 at 08:15 AM.
Here's what investors need to know about the announcement.
Accelerate Diagnostics beat estimated earnings by 17.86%, reporting an EPS of $-0.23 versus an estimate of $-0.28.
Revenue was up $1.06 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 1.62% drop in the share price the next day.
Here's a look at Accelerate Diagnostics's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.